Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-09-01 Catachol-O-methyltransferase inhibitors
| Opicapone Ongentys® |
|
Formulary
|
Second-line therapy to entacapone, in patients who fail to respond to, or are intolerant of, entacapone, in situations where apomorphine therapy has been considered Supported by an ESCA |
|
Links
Administration of depot antipsychotic injections during COVID-19 in stable adult patients- ESCA: Apomorphine
- ESCA: Ropinerole in Restless Legs syndrome
- ESCA: Selegiline
- NICE NG71: Parkinson’s disease in adults
- UKMI Q&A: How do you convert from co-beneldopa (Madopar®) prolonged-release capsules to dispersible tablets?